Skip to main content
. 2015 Nov 9;7(9):9666–9679. doi: 10.18632/oncotarget.5718

Table 3. Top-5 down- and top-5 over-expressed genes in patients who achieved CR, as compared to patients who achieved PR/SD.

Gene Affy ID FC p Description Cytoband
CCND1 208712_at −2.217 0.0189 G1/S-specific cyclin-D1 11q13
DKK1 204602_at −1.868 0.0345 Dickkopf-related protein 1 10q11.2
JAK1 1552611_a_at −1.245 0.0291 Janus kinase 1 1p32.3-p31.3
RUNX3 204198_s_at −0.958 0.0399 runt-related transcription factor 3 1p36
TGFB1 203085_s_at −0.903 0.000495 transforming growth factor beta 1 19q13.1
IKZF1 205039_s_at −0.802 0.0105 IKAROS family zinc finger 1 (ikaros) 7p13-p11.1
CCND2 200953_s_at 3.307 0.000612 G1/S-specific cyclin-D2 12p13
ITGB1 1553678_a_at 1.117 0.0301 integrin beta-1 10p11.2
ENTPD1 207691_x_at 1.068 0.0409 CD39 antigen 10q24
CAV1 212097_at 0.867 0.0219 caveolin-1 7q31.1
HELLS 223556_at 0.841 0.0138 proliferation-associated SNF2-like protein 10q24.2
YES1 202932_at 0.805 0.0354 Yamaguchi sarcoma viral oncogene homolog 1 18p11.31-p11.21